Cardiovascular autonomic dysfunction in parkinsonian patients

Clinical Neuroscience

Volumn 5, Issue 2, 1998, Pages 153-166

  Mathias, Christopher T ^a,b,c,d,e  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Autonomic failure; Multiple system atrophy; Orthostatic hypotension; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; HEART RATE; HUMAN; ORGAN CIRCULATION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME;

AUTONOMIC NERVOUS SYSTEM; BLOOD CIRCULATION; BLOOD PRESSURE; HEART CONDUCTION SYSTEM; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; PARKINSON DISEASE;

EID: 0032470591     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (129)

1. Akinola A, Mathias CJ, Mansfield A, Thomas D, Wolfe J, Nicolaides AN, Tegos T (1999): Cardiovascular, autonomic and plasma catecholamine responses in unilateral and bilateral carotid artery stenosis. J Neurol Neurosurg Psychiatry 67: 428-432.
2. Aminoff MJ, Gross M (1974): Vasoregulatory activity in patients with Huntington's chorea. J Neurol Sci 21:33-38.
3. Ainoff MJ, Wilcox CS (1971): Assessment of autonomic function in patients with a parkinsonian syndrome. Br Med J 4:80-84.
4. Aminoff MJ, Gross M, Laatz B, Vakil SD, Petrie A, Calne DB (1975): Arterial blood pressure in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 38:73-77.
5. Appenzeller O, Goss JE (1971): Autonomic deficits in Parkinson's disease. Arch Neurol 24:50-57.
6. Awerbuch GI, Sandyk R (1992): Autonomic functions in the early stages of Parkinson's disease. Int J Neurosci 65(1-4):7-14.
7. Ballantyne JP (1973): Early and late effects of levodopa on the cardiovascular system in Parkinson's disease. J Neurol Sci 19:97-103.
8. Bannister R, Oppenheimer DR (1972): Degenerative diseases of the autonomic nervous system associated with autonomic failure. Brain 95:457-474.
9. Baratti M, Calzetti S (1984): Fluctuation of arterial blood pressure during end-ofdose akinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 47:1241-1243.
10. Barbeau A, Mars H, Gillo-Joffroy (1971): Adverse clinical side effects of levodopa therapy. In: FH, Markham CH, editors. Recent advances in Parkinson's disease. Oxford: Blackwell. p 203-237.
11. Ben-Shlomo Y, Churchyard A, Head J, Hurwitz B, Overstall P, Ockelford J, Lees A (1995): Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential enquiry. Br Med J 311:1191-1196.
12. Bondar RL, Dunphy PT, Moradshahi P, Kassam MS, Blaber AP, Stein F, Freeman R (1997): Cerebrovascular and cardiovascular responses to graded tilt in patients with autonomic failure. Stroke 28:1677-1685.
13. Briebach T, Laubenberger J, Fischer P-A (1989): Transcranial Doppler sonographic studies of cerebral autoregulation in Shy-Drager syndrome. J Neurol 236:349-350.
14. Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L (1989): The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry 52:962-966.
15. Calne DB, Brennan AS, Spiers D, Stern GM (1970): Hypotension caused by L-dopa. Br Med J 1:474-475.
16. Calne DB, Reid JL, Vakil SD, George CF, Rao S (1973): Effects of carbidopa-levodopa on blood pressure. In: Yahr MD, editor. Treatment of parkinsonism - the role of dopa decarboxylase inhibitors. Advances in neurology. Vol 2. Amsterdam: North Holland.
17. Camerlingo M, Ferrar B, Gazzaniga GC, Casto L, Cesana BM, Mamoli A (1990): Cardiovascular reflexes in Parkinson's disease: long-term effects of levodopa treatment on de novo patients. Acta Neurol Scand 81:346-348.
18. Churchyard A, Mathias CJ, Lees AJ (1997): Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry 63:228-234.
19. Churchyard A, Mathias CJ, Lees AJ (1999): Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal. Movement Disorders 2:246-251.
20. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ (1995): Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 52:294-298.
21. Daniel SE (1999): The neuropathology and neurochemistry of multiple system atrophy. In: Mathias CJ, Bannister R, editors. Autonomic failure. A textbook of clinical disorders of the autonomic netvous system. Oxford: Oxford University Press. p 321-328.
22. Depresseux JC, Rousseau JJ, Franck G (1979): The autoregulation of cerebral blood flow, the cerebrovascular reactivity and their interaction in the Shy-Drager syndrome. Eur Neurol 18:295-301.
23. Durrieu G, Senard JM, Rascol O, Tran MA, Lataste X, Rascol A, Montastruc JL (1990): Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a D1 agonist (CY 208-243). Neurology 40:707-709.
24. Durrieu G, Senard JM, Rascol O, Tran MA, Lataste X, Rascol A, Montastruc JL (1991): Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. Clin Neuropharmacol 14:84-90.
25. Freemon FR (1971): Parkinsonism and cardiac arrhythmias. Lancet 2:83-84.
26. Ghika J, Bogousslavsky J (1997): Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. Arch Neurol 54:1104-1108.
27. Goetz CG, Lutge W, Tanner CM (1986): Autonomic dysfunction in Parkinson's disease. Neurology 36:73-75.
28. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ (1997): Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696-702.
29. Greenacre JK, Teychenne PF, Petrie A, Calne D, Leigh PN, Reid JL (1976): The cardiovascular effects of bromocriptine in parkinsonism. Br J Clin Pharmacol 3:571-574.
30. Gross M, Bannister R, Godwin-Austin R (1972): Orthostatic hypotension in Parkinson's disease. Lancet 1:174-176.
31. Gutrecht JA (1992): Autonomic cardiovascular reflexes in progressive supranuclear palsy. J Auton Nerv Syst 39:29-35.
32. 123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 49:81-84.
33. Hughes AJ, Daniel SE, Kilford L, Less AJ (1992): Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
34. Hunter KR, Hollman A, Laurence DR, Stern GM (1971): Levodopa in parkinsonian patients with heart disease. Lancet 1:932-934.
35. Jenkins RB, Mendelson SH, Lamid S, Klawans HL (1972): Levodopa therapy of patients with parkinsonism and heart disease. Br Med J 3:512-514.
36. Karoum F, Chuang LW, Eisler T, et al. (1982): Metabolism of (-) deprenyl to amphetamine and metamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Ann Neurol 32:503-509.
37. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD (1992): Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology 42:590-593.
38. Kimber JR, Watson L, Mathias CJ (1997): Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth hormone release with clonidine. Lancet 349:1877-1881.
39. Koller W, Glatt S, Vetere-Overfield B, Hassanein R (1989): Falls and Parkinson's disease. Clin Neuropharmacol 12:98-105.
40. Kooner JS, Frankel HL, Mirando N, Peart WS, Mathias CJ (1988): Haemodynamic, hormonal and urinary responses to postural change in tetraplegic and paraplegic man. Paraplegia 26:233-237.
41. Kooner JS, Peart WS, Mathias CJ (1989a): The peptide release inhibitor, octreotide (SMS201-995), prevents the haemodynamic changes following food ingestion in normal human subjects. Q J Exp Physiol 74:569-572.
42. Kooner JS, Raimbach SJ, Watson L, Bannister R, Peart WS, Mathias CJ (1989b): Relationship between splanchnic vasodilatation and post-prandial hypotension in patients with primary autonomic failure. J Hypertens 7:S40-41.
43. Korczyn AD (1990): Treatment of autonomic nervous system disturbances in Parkinson's disease. In: Koller WC, Paulson G, editors. Therapy of Parkinson's disease. New York: Marcel Dekker. p 405-411.
44. Kuno S. (1989): Parkinson's disease and its autonomic disorders. Mod Phys (Tokyo) 9:1214-1219.
45. Kuroiwa Y, Shimada Y, Toyokura Y (1983): Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration and Shy-Drager syndrome. Neurology 33:463-467.
46. Kuzuhara S, Yoshimura M, Mizutani T, Yamanouchi H, Ihara Y (1996): Clinical features of diffuse Lewy body disease in the elderly: analysis of 12 cases. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy bodies. New York: Cambridge University Press. p 153-160.
47. Lerner AJ, Mathias CJ, Rossor MN (2000): Autonomic failure preceding dementia with Lewy bodies. J Neurol (in press).
48. Lieberman AN, Goldstein M, Gopinathan G, Leibowitz M, Neophytides A, Walker R, Hiesiger E, Nelson J (1982): Further studies with pergolide in Parkinson disease. Neurology 32:1181-1184.
49. Lipsitz L (1999): Ageing and the autonomic nervous system. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press. p 534-544.
50. Lo SS, Mathias CJ, St. John Sutton M (1996): QT interval and dispersion in primary autonomic failure. Heart 75:498-501.
51. Ludin SM, Steiger UH, Ludin HP (1987): Autonomic disturbances and cardiovascular reflexes in idiopathic Parkinson's disease. J Neurol 235:10-15.
52. Mallipeddi R, Mathias CJ (1998): Raynaud's phenomenon after sympathetic denervation in patients with primary autonomic failure: questionnaire survey. Br Med J 316:438-439.
53. Mars, Krall (1971): L-dopa and cardiac arrhythmias (letter). N Engl J Med 285: 1439.
54. Martin R, Manzanares R, Molto JM, Canet T, Ruiz C, Matias-Guiu J (1993): Cardiovascular reflexes in Parkinson's disease. Ital J Neurol Sci 14:437-442.
55. Mathias CJ (1991): Disorders of the autonomic nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Vol II. Stoneham, MA: Butterworths. p 1661-1685.
56. Mathias CJ (1995): Orthostatic hypotension - causes, mechanisms and influencing factors. Neurology 45:S6-S11.
57. Mathias CJ (1996): Disorders of the autonomic nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. 2nd ed. Boston: Butterworth-Heinemann. p 1953-1981.
58. Mathias CJ (1997): Autonomic disorders and their recognition. N Engl J Med 10:721-724.
59. Mathias CJ (1999): Can the early presence of autonomous dysfunction aid diagnosis in parkinsonism? J Neurol Neurosurg Psychiatry 67:566.
60. Mathias CJ, Bannister R (1999a): Investigation of autonomic disorders. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press. p 169-195.
61. Mathias CJ, Bannister R (1999b): Postcibal hypotension in autonomic disorders. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press. p 283-295.
62. Mathias CJ, Kimber JR (1998): Treatment of postural hypotension. J Neurol Neurosurg Psychiatry 65:285-289.
63. Mathias CJ, Kimber JR (1999): Postural hypotension - causes, clinical features, investigation and management. Annu Rev Med 50:317-336.
64. Mathias CJ, Williams AC (1994): The Shy-Drager syndrome (and multiple system atrophy). In: Calne DB, editor. Neurodegenerative diseases. 1st ed. Philadelphia: W.B. Saunders. p 743-768.
65. Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R (1986): The effect of desmopressin on nocturnal polyuria, overnight weight loss and morning postural hypotension in patients with autonomic failure. Br Med J 293: 353-354.
66. Mathias CJ, da Costa DF, Fosbraey P, Bannister R, Wood SM, Bloom SR, Christensen NJ (1989): Cardiovascular, biochemical and hormonal changes during food induced hypotension in chronic autonomic failure. J Neurol Sci 94:255-269.
67. Mathias CJ, Holly E, Armstrong E, Shareef M, Bannister R (1991): The influence of food on postural hypotension in three groups with chronic autonomic failure: clinical and therapeutic implications. J Neurol Neurosurg Psychiatry 54:726-730.
68. Mathias CJ, Mallipeddi R, Bleasdale-Barr K (1999): Symptoms associated with orthostatic hypotension. J Neurol 246:893-898.
69. Matthews MR (1999): Autonomic ganglia and preganglionic neurones in autonomic failure. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press. p 329-339.
70. McKeith IG, Galasko D, Kosaka K (1996): Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 47:1113-1124.
71. Meco G, Pratesi L, Bonifati V (1991): Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease. J Neurol 238:195-199.
72. Merello M, Pirtosek Z, Bishop S, Lees AJ (1992): Cardiovascular reflexes in Parkinson's disease: effect of domoperidone and apomorphine. Clin Auton Res 2:215-219.
73. Mesec A, Sega S, Kiauta T (1993): The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses. Clin Auton Res 3:339-344.
74. Meyer JS, Shimazu K, Fukuuchi Y, Ouchi T, Okamoto S, Koto A, Ericsson AD (1973): Cerebral dysautoregulation in central neurogenic orthostatic hypotension (Shy-Drager syndrome). Neurology 23:262-273.
75. Micielli G, Martignoni E, Cavallini A, Sandrini G, Nappi G (1987): Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 37:383-393.
76. Netten PM, de Vos K, Horstink MIM, Hoefnagels WHL (1995): Autonomic dysfunction in Parkinson's disease, tested with a computerized method using a Finapres device. Clin Auton Res 5:85-89.
77. Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, Takahashi A (1999): Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res 9:139-144.
78. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67:189-194.
79. Orskov I, Jakobsen J, Dupont E, de Fine Olivarius B, Christensen NJ (1987): Autonomic function in parkinsonian patients relates to duration of disease. Neurology 37:1173-1178.
80. Ozawa T, Tanaka H, Nakano R, Sato M, Inuzuka T, Soma Y, Yoshimura N, Fukuhara N, Tsuji S (1999): Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 67:542-545.
81. Pakiam AS-I, Bergeron C, Lang AE (1999): Diffuse Lewy body disease presenting as multiple system atrophy. Can J Neurol Sci 26:127-131.
82. Piha SJ, Rinne JO, Rinne UK, Seppanen A (1988): Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clin Neurol Neurosurg 90:221-226.
83. Plaschke M, Schwarz J, Dahlheim H, Backmund H, Trenkwalder C (1997): Cardiovascular and renin responses to head-up tilt tests in parkinsonism. Acta Neurol Scand 96:206-210.
84. Puritz R, Lightman SL, Wilcox CS, Forsling M, Bannister R (1983): Blood pressure and vasopressin in progressive autonomic failure: response to postural stimulation, L-dopa and naloxone. Brain 106:503-511.
85. Puvi-Rajasingham S, Smith GDP, Akinola A, Mathias CJ (1997): Abnormal regional blood flow responses during and after exercise in human sympathetic denervation. J Physiol 505:481-489.
86. Quinn N, Illas A, Lermitte F, Agid Y (1981): Bromocriptine in Parkinson's disease: a study of cardiovascular effects. J Neurol Neurosurg Psychiatry 44:426-429.
87. Rae-Grant A, Young B, Spence JD (1985): Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome. Neurology 35:1085-1086.
88. Rajput AH, Rozdilsky B (1976): Dysautonomia in parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry 39:1092-1100.
89. Rajput AH, Rozdilsky B, Rajput A, Ang L (1990): Levodopa therapy and pathological basis of Parkinson's syndrome. Clin Neuropharmacol 13:553-558.
90. Ray Chaudhuri K, Love-Jones S, Ellis CM, Watson L, Mathias CJ, Clift S, Parkes JD (1997): Postprandial hypotension and parkinsonian state in Parkinson's disease. Movement Disorders 12:877-884.
91. Reid JL, Clane DB, George CF, Pallis C, Vakil SD (1971): Cardiovascular reflexes in parkinsonism. Clin Sci 41:63-67.
92. Sachs C, Bergland B, Kajser L (1985): Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta Neurol Scand 71:37-42.
93. Sandroni P, Ahiskog E, Fealey RD, Low PA (1991): Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1:147-155.
94. Schatz IJ, Bannister R, Freeman RL, Jankovic J, Koller WC, Low PA, Mathias CJ, Polinsky RJ, Quinn NP, Robertson D, Streeten DHP (1996): Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 6:125-126.
95. Senard JM, Valet P, Durrieu G, Berlan M, Tran MA, Montastruc JL, Rascol A, Montastruc P (1990): Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest 20: 613-619.
96. Senard JM, Chamentin B, Rascol A, Montastruc JL (1992): Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension. Clin Auton Res 2:99-104.
97. Senard J-M, Rascol O, Durrieu G, Tran MA, Berlan M, Rascol A, Montrastruc JL (1993): Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson's disease or multiple system atrophy. Clin Neuropharmacol 16:70-76.
98. Senard J-M, Rai S, Lapeyre-Mestre M, Brefel C, Rascol O, Rascol A, Montastruc JL (1997): Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 63:578-589.
99. Seyer-Hansen K (1977): Post-prandial hypotension. Br Med J 2:1262.
100. Singer C, Weiner WJ, Sanchez-Ramos JR (1992): Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 32:134-140.
101. Smith GDP, Mathias CJ (1995): Postural hypotension enhanced by exercise in patients with chronic autonomic failure. Q J Med 88:251-256.
102. Smith GDP, Mathias CJ (1996): Differences in the cardiovascular responses to supine exercise and to standing post-exercise in two clinical subgroups of the Shy-Drager syndrome (multiple system atrophy). J Neurol Neurosurg Psychiatry 61:297-303.
103. Smith GDP, Watson LP, Pavitt DV, Mathias CJ (1995a): Abnormal cardiovascular and catecholamine responses to supine exercise in human subjects with sympathetic dysfunction. J Physiol (London) 485:255-265.
104. Smith GDP, Alam M, Watson LP, Mathias CJ (1995b): Effects of the somatostatin analogue, octreotide, on exercise induced hypotension in human subjects with chronic sympathetic failure. Clin Sci 89:367-373.
105. Smith GDP, Von Der Thusen J, Mathias CJ (1999): Comparison of the blood pressure response to food ingestion in two clinical subgroups of multiple system atrophy. Parkinsonism Related Disorders 4:113-117.
106. Tanner CM, Chhablani R, Goetz CG, Klawans HL (1985): Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease. Neurology 35:918-921.
107. Tanner CM, Goetz CG, Klawans HL (1987): Autonomic nervous system disorders. In: Koller WC, editor. Handbook of Parkinson's disease. New York: Marcel Dekker. p 145-170.
108. Thomaides T, Ray Chaudhuri K, Maule S, Mathias CJ (1992a): Differential responses in superior mesenteric artery blood flow may explain the variant pressor responses to clonidine in two groups with sympathetic denervation. Clin Sci 83:59-64.
109. Thomaides TN, Ray Chaudhuri K, Maule S, Watson L, Marsden CD, Mathias CJ (1992b): Growth hormone response to clonidine in central and peripheral autonomic failure. Lancet 340:263-266.
110. Thomaides T, Bleasdale-Barr K, Chaudhuri KR, Pavitt DV, Marsden CD, Mathias CJ (1993): Cardiovascular and hormonal responses to liquid food challenge in idiopathic Parkinson's disease, multiple system atrophy and pure autonomic failure. Neurology 43:900-904.
111. Titianova E, Karakaneva S, Velcheva I (1997): Orthostatic dysregulation in progressive autonomic failure - a transcranial Doppler sonography monitoring. J Neurol Sci 146:87-91.
112. Turkka JT (1987): Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson's disease. Eur Neurol 26:203-210.
113. Turkka JT, Juujarvi KK, Lapinlampi TO, Myllyla VV (1986): Serum noradrenaline response to standing up in patients with Parkinson's disease. Eur Neurol 25:355-361.
114. Turkka JT, Tolonen U, Myllya VV (1987): Cardiovascular reflexes in Parkinson's disease. Eur Neurol 26:104-112.
115. Turkka J, Suominen K, Tolonen U, Sotaniemi K, Myllyla VV (1997): Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease. Neurology 48:662-667.
116. Uono Y (1973): Parkinsonism and autonomic dysfunction. Auton Nerv Syst (Tokyo) 10:163-170.
117. Vanderhaeghen JJ, Perrier O, Sternon JE (1970): Pathological findings in idiopathic orthostatic hypotension. Arch Neurol 22:207-214.
118. van Dijk GH, Haan J, Zwinderman K, Kremer B, van Hilten BJ, Roos RA (1993): Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration and severity. J Neurol Neurosurg Psychiatry 56:1090-1095.
119. van Dijk J, Haan J, Koenderink M, Raymund A, Roos C (1991): Autonomic nervous function in progressive supranuclear palsy. Arch Neurol 48:1083-1084.
120. Villeneuve A, Berlan M, Lafontan M, Caranobe C, Boneu B, Rascol A, Montastruc JL (1985): Platelet alpha-adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery and after treatment. Eur J Clin Invest 15:403-407.
121. Von der Thusen JH, Smith GDP, Bleasdale-Barr K, Mathias CJ (1996): Differences in postprandial hypotension in two subtypes with human central autonomic failure (Shy-Drager syndrome/multiple system atrophy). J Physiol 495:129P.
122. Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Ray Chaudhuri K, Jellinger K, Poewe W, Litvan I (1999): Time course of symptomatic orthostatic hypotension and urinary incontinence in post-mortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 67:620-623.
123. Wieling W, van Lieshout JJ, van Leeuwen AM (1993): Physical manoeuvres that reduce postural hypotension. Clin Auton Res 3:57-65.
124. Wilcox CS, Aminoff MJ (1976): Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome. Br J Clin Pharmacol 3:207-214.
125. Wilcox CS, DiBona GF (1999): The kidney and the sympathetic nervous system. In: Mathias CJ, Bannister R, editors. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press. p 143-150.
126. Wilcox CS, Aminoff MJ, Slater JDH (1977): Sodium homeostasis in patients with autonomic failure. Clin Sci 53:321-328.
127. Yahr MD (1970): General discussion on clinical effects of L-dopa upon blood pressure. In: Barbeau A, McDowell FH, editors. L-dopa and parkinsonism. Philadelphia: F.A. Davis. p 266-268.
128. Yoshita M (1998): Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 and metaiodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60-67.
129. Zoukos Y, Thomaides T, Pavitt DV, Cuzner ML, Mathias CJ (1993): Beta-adrenoceptor expression on circulating mononuclear cells of idiopathic Parkinson's disease and autonomic failure patients before and after reduction of central sympathetic outflow by clonidine. Neurology 43:1181-1187.